|
Jul 25
|
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
|
|
Jun 10
|
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
|
|
May 3
|
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
|
|
Apr 30
|
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
|
|
Apr 4
|
BioSig Engages Consulting Firm for Business Model Strategies
|
|
Jan 31
|
BioSig Announces Reverse Stock Split
|
|
Jan 30
|
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
|
|
Dec 12
|
Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
|
|
Dec 6
|
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024
|
|
Nov 7
|
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
|
|
Nov 2
|
BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac Care
|